Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Lamblin

Showing results (51-60 of 163) with videos related to

Pageof 17
Sort By:
American Heart Journal|September 26, 2006
The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patientsPascal de Groote, Nicolas Lamblin, Nicole Helbecque, et al.
International Journal of Molecular Sciences|November 8, 2019
Let-7f: A New Potential Circulating Biomarker Identified by miRNA Profiling of Cells Isolated from Human Abdominal Aortic AneurysmRafaelle Spear, Ludovic Boytard, Renaud Blervaque, et al.
ESC Heart Failure|May 24, 2024
Salt substitute recommendations for heart failure patients may influence guideline-directed medical therapies titrationJean-Michel Tartière, François Roubille, Muriel Salvat, et al.
European Heart Journal|April 16, 2004
Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunctionFrédérique Mizon-Gérard, Pascal de Groote, Nicolas Lamblin, et al.
Pharmacoeconomics - Open|August 22, 2023
Public Health Impact and Cost-Effectiveness of Empagliflozin (JARDIANCE<sup>®</sup>) in the Treatment of Patients with Heart Failure with Preserved Ejection Fraction in France, Based on the EMPEROR-Preserved Clinical TrialLaurent Fauchier, Nicolas Lamblin, Jean Tardu, et al.
European Radiology|August 3, 2016
Lung perfusion characteristics in pulmonary arterial hypertension (PAH) and peripheral forms of chronic thromboembolic pulmonary hypertension (pCTEPH): Dual-energy CT experience in 31 patientsJessica Giordano, Suonita Khung, Alain Duhamel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 25, 2025
Safety and efficacy of early use of mineralocorticoid receptor antagonists in cardiogenic shock: a propensity score-matched analysisMiloud Cherbi, François Roubille, Paul Gautier, et al.
American Heart Journal|August 9, 2005
Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failureNicolas Lamblin, Sophie Susen, Joël Dagorn, et al.
Chest|October 14, 2003
Aspirin does not adversely affect survival in patients with stable congestive heart failure treated with Angiotensin-converting enzyme inhibitorsValérie Aumégeat, Nicolas Lamblin, Pascal de Groote, et al.
American Heart Journal|August 17, 2004
Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure?Pascal de Groote, Benoît Soudan, Nicolas Lamblin, et al.
Pageof 17

Showing results (51-60 of 163) with videos related to

Sort By:
Pageof 17
American Heart Journal|September 26, 2006
The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patientsPascal de Groote, Nicolas Lamblin, Nicole Helbecque, et al.
International Journal of Molecular Sciences|November 8, 2019
Let-7f: A New Potential Circulating Biomarker Identified by miRNA Profiling of Cells Isolated from Human Abdominal Aortic AneurysmRafaelle Spear, Ludovic Boytard, Renaud Blervaque, et al.
ESC Heart Failure|May 24, 2024
Salt substitute recommendations for heart failure patients may influence guideline-directed medical therapies titrationJean-Michel Tartière, François Roubille, Muriel Salvat, et al.
European Heart Journal|April 16, 2004
Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunctionFrédérique Mizon-Gérard, Pascal de Groote, Nicolas Lamblin, et al.
Pharmacoeconomics - Open|August 22, 2023
Public Health Impact and Cost-Effectiveness of Empagliflozin (JARDIANCE<sup>®</sup>) in the Treatment of Patients with Heart Failure with Preserved Ejection Fraction in France, Based on the EMPEROR-Preserved Clinical TrialLaurent Fauchier, Nicolas Lamblin, Jean Tardu, et al.
European Radiology|August 3, 2016
Lung perfusion characteristics in pulmonary arterial hypertension (PAH) and peripheral forms of chronic thromboembolic pulmonary hypertension (pCTEPH): Dual-energy CT experience in 31 patientsJessica Giordano, Suonita Khung, Alain Duhamel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 25, 2025
Safety and efficacy of early use of mineralocorticoid receptor antagonists in cardiogenic shock: a propensity score-matched analysisMiloud Cherbi, François Roubille, Paul Gautier, et al.
American Heart Journal|August 9, 2005
Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failureNicolas Lamblin, Sophie Susen, Joël Dagorn, et al.
Chest|October 14, 2003
Aspirin does not adversely affect survival in patients with stable congestive heart failure treated with Angiotensin-converting enzyme inhibitorsValérie Aumégeat, Nicolas Lamblin, Pascal de Groote, et al.
American Heart Journal|August 17, 2004
Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure?Pascal de Groote, Benoît Soudan, Nicolas Lamblin, et al.
Pageof 17